Total Pageviews

Monday, March 14, 2022

Report on Evaluation of Innovation Excellence Indicators of Public Funded R&D Organisations


 

A quality report but wrongly titled as talk of  innovation excellence is pre-mature.

A total of 193 R&D labs were considered for this report from out of 660 listed in DST directory. A  majority 70% have either not responded or do not have details for analysis, strange considering this is an initiate of Office of Principal Scientific Adviser. Innovation Excellence is covered under the pillar Science, Technology & Innovation Excellence' which measured Scholarly Research Output, Development and Innovation Output , Commercialisation of TechnologiesRevenue Generation and Collaborative Research. The findings:

  • The patent filings have slowed from 657 in 2017-18 to around 605 in 2019-20. The patents filed for by the 193 labs account for around 2 percent of the total patents filed within India and outside India by Indian residents. In terms of patents granted, the 193 labs accounted for around 8 percent of the total patents granted within India and outside India to residents in India.
  • A total of 1513 new products and 1480 new services were introduced in the period under consideration. Of the 193 labs, there were 46 labs that did not introduce a single new product or service in any of the three years.
  • The labs earned over Rs 5300 Cr over the three year period, with the main contribution coming from earnings through consultancy fees. The earnings through consultancy fees through non-government is however driven by a small number of labs that are also engaged in providing services to specific sectors like manufacturing, infrastructure and healthcare whereas the government consultancy earnings are driven by sectors such as electronics and infrastructure among others. Earning from commercialization (2019-20) was Rs 31 crores from government sources and Rs 36 crores from no- government sources. Extra mural funding from government sources was Rs 3959 crores from government sources and  Rs 259 crores from non-government sources.
The labs reported 1192 technologies in 2019-20 alone as TRL 5 and above targeted towards SDGs. Their  meaning is not clear to me.

Micro level data

Volume II has lab level data, two taken for illustration.

CEERI

Engineering is the bugbear of CSIR labs. This lab in electronics and statistics for 10 crore spend in 2019-20.

  • number of patented filed- 0
  • number of patents licensed out-0
  • contribution to standards , regulation-0
  • new products/ services introduced-0.23
  • earnings from government sources- 0.02
  • earnings from non- government sources-0.14
Institute of Nano Science and Technology

Some labs are always in the news, riding the hype curve.
  • Number of PhDs, Masters and Graduate degrees awarded by the lab or awarded through collaboration with a University (per 100 scientific staff)- 13.92
  • Whether the PhDs have been examined by one or more foreign assessors as an organisation policy- NIL
  • Number of national awards and recognitions and fellowships received by members of the lab (per 100 scientific staff) -0
  • Number of international awards and recognitions and fellowships received by members of the lab (per 100 scientific staff)-0
  • Number of publications in quality peer reviewed journals (per 100 scientific staff-115
  • Number of citations received by papers published in the preceding three calendar years (per 100 scientific staff)-1690
  • Percentage of publications in top 10% journals-8.33
  • Number of commissioned technology development/ design/project reports prepared (per 100 scientific staff)-0
  • Number of IPRs filed (per Rs.10 Cr spent)-0.47
Recommendations
The present study reveals that there has been an increase in international technology transfers from14 in 2017-18 to 20 in 2019-20, but a gradual decline in the numbers of domestic technology transfers, from 636 in 2017-18 to 613 in 2019-20.
  • Allocation of certain financial resources to all labs which can be mobilized additionally for translational research, pilot plant trials and scale-up. of the technologies developed in the labs for their improvement in ‘Technology Readiness Levels’. 
  • In order to encourage the scientists to enhance the volume and value of IPRs and subsequent technology transfer, it may be useful to have provisions for definitive career interventions like financial incentives (cash awards, additional increments etc.) and preferential promotional rules.



No comments: